Research teams are stretched thin.
Coordinators spend hours on manual chart review. Eligible patients slip through the cracks. Studies under-enroll while matching patients sit in your EHR, invisible.
Let Lind do the heavy lifting.
Watch Lind prescreen a real patient criterion by criterion, with evidence pulled straight from the chart.
Right patient, right trial, at scale.
Automated screening across every patient and every study — embedded in your EHR.
Surface eligible patients
Screening across every patient in your system. Trial-arm level match scoring, embedded directly in the EHR with zero disruption to clinical workflows.
- Works across all indications
- Screen for all studies at your health system
- Easy to navigate and filter to find the best options
Pre-screen with confidence
Expert-level criteria matching powered by AI, with source evidence pulled directly from the patient record. Every decision is explainable and auditable.
- Explanation with links directly into the health record
- Decision deferred to users when clinical judgment is required
- Absence of evidence and evidence of absence highlighted
Powering an intelligent site network
Every health system on the Lind Platform adds to a growing network of research-ready sites with verified patient populations. For sponsors, that means faster enrollment, better site selection, and studies designed around real-world data — not guesswork.
Stronger sites. Smarter protocols. Powered by real-world data.
Run your trials on the Lind network. Real-world patient data and site-level intelligence to accelerate enrollment and de-risk study design.
Activate high-quality sites
Identify the right sites before study startup. Real-world patient density data across the Lind network helps you select higher-performing sites and compress time to enrollment.
- Real-world patient density by site
- Data-driven site selection and ranking
- Accelerated study startup
Optimize trial protocols
See which eligibility criteria are filtering out patients before enrollment starts. Cohort modeling and per-criterion insights help de-risk study design.
- Per-criterion eligibility insights
- Cohort modeling and bias reduction
- Protocol rescue for under-accruing studies
Clinically validated.
Operationally effective.
Accuracy that matches expert physicians, deployed at enterprise scale across real health systems.
Clinically validated
- 97% screening accuracy validated against expert oncologists at major academic centers
- Peer-reviewed: in-review with JCO and ASCO; presented at AACR; NCI co-publication
- Production-scale: 224K+ patient records processed across 90+ active studies daily
Deployed at scale
- Live with 3 health system partners covering 17M patients across 86 hospitals
- Disease-agnostic: oncology, dermatology, hematology, neurology and expanding
- FHIR-native integration with multiple EHR platforms, data-source agnostic by design
Every patient deserves to know about the trial that could save their life
Today, 91% never do.
No more invisible patients.